SCHEMBL22803124

SCHEMBL22803124

Cc1c(C(C)(C)C)ccc2c1NCCO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 6/20 0.49
▸ ADRA2C P18825 5/20 0.49
▸ ADRA1D P25100 5/20 0.49
▸ ADRA1A P35348 5/20 0.49
▸ ADRA1B P35368 5/20 0.49
▸ ADRA2B P18089 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAP4K1 Q92918 1/20 0.34
▸ FABP6 P51161 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.32
▸ TRPV1 Q8NER1 2/20 0.32
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ STING1 Q86WV6 1/20 0.32
▸ LMNA P02545 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ HTR1A P08908 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792864 0.83 ADRA2A (0.33) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL13036175 0.79 ADRA2A (0.54) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL13439881 0.78 ADRA2A (0.38) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL16931646 0.77 ADRA2A (0.52) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL23771373 0.76 ADRA2A (0.51) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL15996957 0.76 ADRA2A (0.51) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL10157242 0.76 ADRA2A (0.51) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL15052696 0.76 ADRA2A (0.51) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL22691743 0.73 ADRA2A (0.49) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL10157972 0.73 ADRA2A (0.49) ADRA2AADRA2CADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037342-B2 Substituted eneoxindoles and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-16 — — US disclosed
US-20230183262-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF GILEAD SCIENCES, INC. 2023-06-15 — — US disclosed
US-20200392153-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF GILEAD SCIENCES, INC. 2020-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183262-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF HIPK1, HPGDS, HIPK3 ADRA2A 3625/4885ADRA2C 3136/4885ADRA1D 2066/4885
US-12037342-B2 Substituted eneoxindoles and uses thereof HIPK1, HPGDS, HIPK3 ADRA2A 3625/4885ADRA2C 3136/4885ADRA1D 2066/4885
US-20200392153-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF HIPK1, HPGDS, HIPK3 ADRA2A 3625/4885ADRA2C 3136/4885ADRA1D 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback